Renovaro Biosciences
RENB
#8953
Rank
A$0.12 B
Marketcap
$0.80
Share price
3.63%
Change (1 day)
-82.71%
Change (1 year)

EPS for Renovaro Biosciences (RENB)

EPS in 2023 (TTM): -$2.95

According to Renovaro Biosciences's latest financial reports the company's current EPS (TTM) is -$3.11. In 2022 the company made an earnings per share (EPS) of -$3.17 a decrease over its 2021 EPS that were of -$1.21.

EPS history for Renovaro Biosciences from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.95-6.82%
2022-$3.17160.76%
2021-$1.21243.48%
2020-$0.3543.75%
2019-$0.25-74.87%
2018-$0.98339.47%
2017-$0.22-48.26%
2016-$0.43-22.22%
2015-$0.557.39%
2014-$0.524351.27%
2013-$0.0115816.6%
2012-$0.009931